- Home
- CBNA vs DRTS Comparison
CBNA vs DRTS Comparison
Compare CBNA & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBNA
- DRTS
- Stock Information
- Founded
- CBNA 2006
- DRTS 2015
- Country
- CBNA United States
- DRTS Israel
- Employees
- CBNA N/A
- DRTS N/A
- Industry
- CBNA
- DRTS Medical/Dental Instruments
- Sector
- CBNA
- DRTS Health Care
- Exchange
- CBNA NYSE
- DRTS Nasdaq
- Market Cap
- CBNA 133.2M
- DRTS 159.1M
- IPO Year
- CBNA 2024
- DRTS N/A
- Fundamental
- Price
- CBNA $24.00
- DRTS $3.09
- Analyst Decision
- CBNA Buy
- DRTS Strong Buy
- Analyst Count
- CBNA 3
- DRTS 2
- Target Price
- CBNA $27.67
- DRTS $8.00
- AVG Volume (30 Days)
- CBNA 32.5K
- DRTS 59.5K
- Earning Date
- CBNA 02-15-2025
- DRTS 11-19-2024
- Dividend Yield
- CBNA N/A
- DRTS N/A
- EPS Growth
- CBNA 135.51
- DRTS N/A
- EPS
- CBNA 4.49
- DRTS N/A
- Revenue
- CBNA $49,968,000.00
- DRTS N/A
- Revenue This Year
- CBNA N/A
- DRTS N/A
- Revenue Next Year
- CBNA N/A
- DRTS N/A
- P/E Ratio
- CBNA $5.34
- DRTS N/A
- Revenue Growth
- CBNA 76.01
- DRTS N/A
- 52 Week Low
- CBNA $20.10
- DRTS $1.75
- 52 Week High
- CBNA $27.56
- DRTS $3.40
- Technical
- Relative Strength Index (RSI)
- CBNA N/A
- DRTS 69.66
- Support Level
- CBNA N/A
- DRTS $3.03
- Resistance Level
- CBNA N/A
- DRTS $3.20
- Average True Range (ATR)
- CBNA 0.00
- DRTS 0.09
- MACD
- CBNA 0.00
- DRTS -0.02
- Stochastic Oscillator
- CBNA 0.00
- DRTS 65.62
About CBNA CHAIN BRIDGE BANCORP INC
Chain Bridge Bancorp Inc is engaged in banking industry. It offers commercial and personal banking services, including deposits, treasury management, payments, loans, commercial lending, residential mortgage financing, consumer loans, trusts and estate administration, wealth management, and asset custody.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.